Unraveling the early events of amyloid-β protein (Aβ) aggregation: techniques for the determination of Aβ aggregate size.
about
Confocal Spectroscopy to Study Dimerization, Oligomerization and Aggregation of Proteins: A Practical GuideInvestigation of stable and transient protein-protein interactions: Past, present, and futureAntiaggregation Potential of Padina gymnospora against the Toxic Alzheimer's Beta-Amyloid Peptide 25-35 and Cholinesterase Inhibitory Property of Its Bioactive CompoundsUltrasonic force microscopy for nanomechanical characterization of early and late-stage amyloid-β peptide aggregation.Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.Capillary electrophoresis for the analysis of the effect of sample preparation on early stages of Aβ1-40 aggregation.Therapeutic potential of mGluR5 targeting in Alzheimer's diseaseNeuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.Protective spin-labeled fluorenes maintain amyloid beta peptide in small oligomers and limit transitions in secondary structure.Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysinResolution of oligomeric species during the aggregation of Aβ1-40 using (19)F NMR.Field amplified sample stacking of amyloid beta (1-42) oligomers using capillary electrophoresis.Experimental traumatic brain injury induces rapid aggregation and oligomerization of amyloid-beta in an Alzheimer's disease mouse model.Advances in electrochemical detection for study of neurodegenerative disorders.Chronic stress exposure following photothrombotic stroke is associated with increased levels of Amyloid beta accumulation and altered oligomerisation at sites of thalamic secondary neurodegeneration in mice.Charge regulation phenomenon predicted from the modeling of polypeptide electrophoretic mobilities as a relevant mechanism of amyloid-beta peptide oligomerization.Particle sizing methods for the detection of protein aggregates in biopharmaceuticals.Inhibition of amyloid fibril growth and dissolution of amyloid fibrils by curcumin-gold nanoparticles.Global properties and propensity to dimerization of the amyloid-beta (12-28) peptide fragment through the modeling of its monomer and dimer diffusion coefficients and electrophoretic mobilities.An improved capillary electrophoresis method for in vitro monitoring of the challenging early steps of Aβ1-42 peptide oligomerization: application to anti-Alzheimer's drug discovery.Phytol-loaded PLGA nanoparticle as a modulator of Alzheimer's toxic Aβ peptide aggregation and fibrillation associated with impaired neuronal cell function.Assessment of anti-amyloidogenic activity of marine red alga G. acerosa against Alzheimer's beta-amyloid peptide 25-35.Inhibition of Protein Aggregation by Several Antioxidants.A discrete mathematical model for the aggregation of β-Amyloid.Liquid Crystal Enabled Early Stage Detection of Beta Amyloid Formation on Lipid MonolayersRecent Advances by In Silico and In Vitro Studies of Amyloid-β 1-42 Fibril Depicted a S-Shape Conformation
P2860
Q26752808-84F6FF49-461A-4458-98C9-61B06DDCB6A3Q27002299-28D19013-B311-49BD-A9C2-DBEB9C4CD94AQ28550688-3EEC27A0-B900-4349-827D-3DCEAFBC13A1Q30443330-5D523D44-E41E-4B86-BA03-E227753AD3D8Q34227162-E3C17FC3-753B-4C23-915D-44C990D04C59Q35525142-CAB78C89-89F5-49EE-8C34-7F07890C16ADQ35698522-ED7F7495-5F95-4C3E-95B9-AF4DDE08DE2BQ35974488-8094AAB4-CF67-47F5-BD8A-5DDFEC9ECB89Q36244824-E1F23A18-4928-4456-8971-5DDBF0BC9676Q36319298-8C3D6FB5-7214-47CC-B8AE-A322D95B6271Q36772928-9B1A6EDA-A9BE-4545-8C7F-53E4E0D37E82Q37017555-5C458DB1-FF88-4228-83DF-17574A1DFB89Q37573798-A9A48F4B-EF29-4F82-BC7A-F86EDA308971Q38093077-71C16AA1-B5AC-45F9-9632-5EF128D3556CQ38848733-7508D8B7-E0F4-43D1-852B-DB22F138F58DQ38926076-067C3260-AC1F-415B-BA8F-F4AC89126364Q39093458-EDAE4CF7-6EF6-4548-A5FB-F150BBDDE282Q44171513-A3B09A8D-B82E-4F8A-A95A-780A1EF4BEDAQ45776528-DF1C7C94-02D3-4E8F-AE6E-72C9F5D7B5F3Q46838942-E670884C-8652-4E49-AAAE-3D7D24E59B88Q47566506-AC9A593A-992D-422E-8AF3-8B4A9AFEAE07Q50466058-B7F2AF92-21AE-435A-881D-1317273FBAE2Q55276020-77A23E2B-AE75-4DAD-B265-3CEBB21B59FDQ55322228-CF00404C-1500-4753-9603-BAC78A6F0EBCQ57340675-527A59F1-6045-4155-8605-04C804FBCD4DQ58772925-79790FFB-8252-428D-AEFA-EFFB693C8D7E
P2860
Unraveling the early events of amyloid-β protein (Aβ) aggregation: techniques for the determination of Aβ aggregate size.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Unraveling the early events of ...... mination of Aβ aggregate size.
@ast
Unraveling the early events of ...... mination of Aβ aggregate size.
@en
Unraveling the early events of amyloid-β protein
@nl
type
label
Unraveling the early events of ...... mination of Aβ aggregate size.
@ast
Unraveling the early events of ...... mination of Aβ aggregate size.
@en
Unraveling the early events of amyloid-β protein
@nl
prefLabel
Unraveling the early events of ...... mination of Aβ aggregate size.
@ast
Unraveling the early events of ...... mination of Aβ aggregate size.
@en
Unraveling the early events of amyloid-β protein
@nl
P2093
P2860
P921
P356
P1476
Unraveling the early events of ...... mination of Aβ aggregate size.
@en
P2093
Christa N Hestekin
Melissa A Moss
N Elizabeth Pryor
P2860
P304
P356
10.3390/IJMS13033038
P407
P5008
P577
2012-03-07T00:00:00Z